ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 445,69
2,24%
Dow Jones
42 706,56
-0,06%
DAX
20 216,19
1,54%
Brent Oil
76,075
-0,56%
Bitcoin
101 789,98
3,52%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Acal (ACL) Cours

Acal

Acal (ACL)

Australian Clinical Labs Limited
320,25
0,00
(0,00%)
Fermé 06 Janvier 5:30PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
320,25
Prix Achat
320,00
Prix Vente
324,75
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
320,25
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

ACL Dernières nouvelles

Plus de nouvelles

Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon

-- Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration -- Deal provides path for Alcon to acquire Potentia LOUISVILLE, Ky., Oct. 23...

23 Octobre 2009
PR Newswire (US)

NovaBay Pharmaceuticals to Present at Maxim Group Growth Conference

Presentation to be Webcast on September 29, 2009 EMERYVILLE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE-AMEX: NBY) http://www.novabaypharma.com/, a clinical...

24 Septembre 2009
PR Newswire (US)

/C O R R E C T I O N -- Agency.com/

In the news release, Agency.com Helps Launch the New Alcon.com, issued earlier today by Agency.com over PR Newswire, we are advised by the company that the phone number in the contact...

29 Janvier 2007
PR Newswire (US)

Alcon Views AMO Patent Lawsuit as Meritless

Alcon Views AMO Patent Lawsuit as Meritless FORT WORTH, Texas, Dec. 16 /PRNewswire-FirstCall/ -- On December 3, 2003, Advanced Medical Optics (AMO) filed a complaint against Alcon Laboratories...

17 Décembre 2003
PR Newswire (US)

Director Declaration

RNS Number:8575S Acal PLC 04 December 2003 Appointment of Mr Graham Williams as a Non-Executive Director On 1st December 2003 Acal plc announced the appointment of Mr Graham Williams...

04 Décembre 2003
UK Regulatory

Interim Results

RNS Number:6614S Acal PLC 01 December 2003 FOR RELEASE 7:00AM 1 DECEMBER 2003 ACAL plc (Leading pan-European, value added distributor providing specialist design-in, sales and...

01 Décembre 2003
UK Regulatory

Notice of Results

RNS Number:9575R Acal PLC 12 November 2003 FOR RELEASE 7.00AM 12 NOVEMBER 2003 ACAL PLC (Acal is a leading European value-added distributor providing specialist design-in, sales...

12 Novembre 2003
UK Regulatory

Holding(s) in Company

RNS Number:9135R Acal PLC 11 November 2003 Acal plc (the "Company") received notice on 10 November 2003 that, for the purposes of Part VI of the Companies Act 1985 (as amended) Prudential...

11 Novembre 2003
UK Regulatory

Holding(s) in Company

RNS Number:4111R Acal PLC 28 October 2003 Acal PLC 28 October 2003 Schedule 10 - Notification of Major Interests in Shares On 27 October 2003 the Company received the following...

28 Octobre 2003
UK Regulatory

Blocklisting Interim Review

RNS Number:9053Q Acal PLC 14 October 2003 BLOCKLISTING SIX MONTHLY REVIEW 1. NAME OF COMPANY: ACAL PLC 2. NAME OF SCHEME: ACAL EXECUTIVE SHARE OPTION SCHEME 3. PERIOD...

14 Octobre 2003
UK Regulatory
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

ACL - Frequently Asked Questions (FAQ)

What is the current Acal share price?
The current share price of Acal is 320,25p
What is the 1 year trading range for Acal share price?
Acal has traded in the range of 0,00p to 0,00p during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SCGLSealand Capital Galaxy Limited
3,25p
(103,13%)
12,18M
BORBorders & Southern Petroleum Plc
3,64p
(51,04%)
23,81M
NEONeo Energy Metals Plc
0,95p
(22,58%)
37,84M
GNIPGenip Plc
32,00p
(20,75%)
192,82k
ZIOCZanaga Iron Ore Company Limited
10,50p
(19,86%)
2,84M
DGIDg Innovate Plc
0,02p
(-20,00%)
298,54M
SNGSynairgen Plc
2,10p
(-19,39%)
1,67M
VRSVersarien Plc
0,03p
(-18,92%)
103,72M
QEDQuadrise Plc
5,90p
(-17,83%)
17,66M
ZENZenith Energy Ltd.
4,90p
(-16,24%)
1,48M
SYMESupply@me Capital Plc
0,0042p
(12,00%)
1,19B
MSMNMosman Oil And Gas Limited
0,035p
(12,90%)
654,48M
TRPTower Resources Plc
0,0395p
(0,00%)
570,56M
CPXCap-xx Limited
0,1775p
(-2,74%)
379,2M
NTVONativo Resources Plc
0,0019p
(-5,00%)
312,89M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
ACL
Acal
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés